(Q52003006)

19 April 2018

title

Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. (English)

1 reference

19 April 2018

0 references

1 reference

Hecker M

1

1 reference

19 April 2018

Qiu D

2

1 reference

19 April 2018

Marquardt K

3

1 reference

19 April 2018

Bein G

4

1 reference

19 April 2018

Hackstein H

5

1 reference

19 April 2018

publication date

1 January 2004

1 reference

19 April 2018

published in

Vox Sanguinis

1 reference

19 April 2018

volume

86

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

41-44

1 reference

19 April 2018

The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

Cytomegalovirus antibody status and renal transplantation: 1987-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

CMV and blood transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

Asymptomatic primary cytomegalovirus infection: virologic and immunologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

CMV DNA is rarely detected in healthy blood donors using validated PCR assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0042-9007.2004.00388.X

10.1111/J.0042-9007.2004.00388.X

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

14984558

1 reference

19 April 2018